80 FR 15227 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 55 (March 23, 2015)

Page Range		15227-15228
FR Document		2015-06596

Federal Register, Volume 80 Issue 55 (Monday, March 23, 2015)

[Federal Register Volume 80, Number 55 (Monday, March 23, 2015)]
[Notices]
[Pages 15227-15228]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06596]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Drug Discovery.
    Date: April 2, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Peter B. Guthrie, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4142, MSC 7850, Bethesda, MD 
20892, (301) 435-1239, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Exercise in aging, ischemia imaging.
    Date: April 2, 2015.
    Time: 12:01 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Samuel C. Edwards, Ph.D., IRG CHIEF, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 5210, MSC 7846, Bethesda, MD 20892, (301) 435-1246, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.


[[Page 15228]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)



    Dated: March 18, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06596 Filed 3-20-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 55 / Monday, March 23, 2015 / Notices 15227

ADDRESSES: Requests for copies of the DEPARTMENT OF HEALTH AND Dated: March 17, 2015.
patent applications, inquiries, HUMAN SERVICES Melanie J. Gray,
comments, and other materials relating Program Analyst, Office of Federal Advisory
to the contemplated exclusive National Institutes of Health Committee Policy.
evaluation option license should be [FR Doc. 2015–06476 Filed 3–20–15; 8:45 am]
directed to: Jennifer Wong, M.S., Senior National Cancer Institute; Notice of BILLING CODE 4140–01–P
Licensing and Patenting Manager, Office Closed Meeting
of Technology Transfer, National
Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND
Institutes of Health, 6011 Executive
Federal Advisory Committee Act, as HUMAN SERVICES
Boulevard, Suite 325, Rockville, MD
amended (5 U.S.C. Appendix 2); notice
20852–3804; Telephone: (301) 435–
is hereby given of the following National Institutes of Health
4633; Facsimile: (301) 402–0220; Email: meeting.
wongje@od.nih.gov. Center for Scientific Review; Notice of
The meeting will be closed to the
SUPPLEMENTARY INFORMATION: Tyrosine public in accordance with the Closed Meetings
kinase-like orphan receptor 1 (ROR1) is provisions set forth in sections Pursuant to section 10(d) of the
a signature cell surface antigen for B-cell 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Federal Advisory Committee Act, as
malignancies, most notably, B-cell as amended. The purpose of this amended (5 U.S.C. App.), notice is
chronic lymphocytic leukemia (B–CLL) meeting is to evaluate requests for hereby given of the following meetings.
and mantle cell lymphoma (MCL) cells, preclinical development resources for The meetings will be closed to the
two incurable diseases. The potential new therapeutics for the public in accordance with the
investigators have developed a portfolio treatment of cancer. The outcome of the provisions set forth in sections
of chimeric anti-ROR1 monoclonal evaluation will provide information to 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
antibodies that selectively target ROR1 internal NCI committees that will as amended. The grant applications and
malignant B-cells but not normal B- decide whether NCI should support the discussions could disclose
cells. These antibodies may be linked to requests and make available contract confidential trade secrets or commercial
chemical drugs or biological toxins thus resources for development of the property such as patentable material,
providing targeted cytotoxic delivery to potential therapeutic to improve the and personal information concerning
malignant B-cells while sparing normal treatment of various forms of cancer. individuals associated with the grant
cells. Moreover, as these antibodies The research proposals and the applications, the disclosure of which
selectively target ROR1, they can also be discussions could disclose confidential would constitute a clearly unwarranted
used to diagnose B-cell malignancies. trade secrets or commercial property invasion of personal privacy.
The prospective start-up exclusive such as patentable material, and Name of Committee: Center for Scientific
evaluation option license is being personal information concerning Review Special Emphasis Panel; Drug
considered under the small business individuals associated with the Discovery.
initiative launched on October 1, 2011 proposed research projects, the Date: April 2, 2015.
and will comply with the terms and disclosure of which would constitute a Time: 1:00 p.m. to 3:00 p.m.
conditions of 35 U.S.C. 209 and 37 CFR clearly unwarranted invasion of Agenda: To review and evaluate grant
personal privacy. applications.
part 404. The prospective start-up Place: National Institutes of Health, 6701
exclusive evaluation option license, and Name of Committee: National Cancer Rockledge Drive, Bethesda, MD 20892,
a subsequent start-up exclusive patent Institute Special Emphasis Panel; Feb2015 (Telephone Conference Call).
commercialization license, may be Cycle 19 NExT SEP Committee Meeting. Contact Person: Peter B. Guthrie, Ph.D.,
granted unless within fifteen (15) days Date: April 29, 2015. Scientific Review Officer, Center for
from the date of this published notice, Time: 8:30 a.m. to 4:30 p.m. Scientific Review, National Institutes of
the NIH receives written evidence and Agenda: To evaluate the NCI Experimental Health, 6701 Rockledge Drive, Room 4142,
Therapeutics Program Portfolio. MSC 7850, Bethesda, MD 20892, (301) 435–
argument that establishes that the grant Place: National Institutes of Health, 9000 1239, guthriep@csr.nih.gov.
of the license would not be consistent Rockville Pike, Campus Building 31, This notice is being published less than 15
with the requirements of 35 U.S.C. 209 Conference Room 6C10, Bethesda, MD 20892. days prior to the meeting due to the timing
and 37 CFR part 404. Contact Persons: Barbara Mroczkowski, limitations imposed by the review and
Any additional, properly filed, and Ph.D., Executive Secretary, Discovery funding cycle.
complete applications for a license in Experimental Therapeutics Program, Name of Committee: Center for Scientific
National Cancer Institute, NIH, 31 Center Review Special Emphasis Panel; Member
the field of use filed in response to this Drive, Room 3A44, Bethesda, MD 20817,
notice will be treated as objections to Conflict: Exercise in aging, ischemia imaging.
(301) 496–4291, mroczkoskib@mail.nih.gov; Date: April 2, 2015.
the grant of the contemplated start-up Joseph Tomaszewski, Ph.D., Executive Time: 12:01 p.m. to 1:30 p.m.
exclusive evaluation option license. Secretary, Development Experimental Agenda: To review and evaluate grant
Comments and objections submitted to Therapeutics Program, National Cancer applications.
this notice will not be made available Institute, NIH, 31 Center Drive, Room 3A44, Place: National Institutes of Health, 6701
for public inspection and, to the extent Bethesda, MD 20817, (301) 496–6711, Rockledge Drive, Bethesda, MD 20892,
permitted by law, will not be released tomaszej@mail.nih.gov. (Telephone Conference Call).
under the Freedom of Information Act, (Catalogue of Federal Domestic Assistance Contact Person: Samuel C. Edwards, Ph.D.,
Program Nos. 93.392, Cancer Construction; IRG CHIEF, Center for Scientific Review,
mstockstill on DSK4VPTVN1PROD with NOTICES

5 U.S.C. 552.
93.393, Cancer Cause and Prevention National Institutes of Health, 6701 Rockledge
Dated: March 16, 2015. Research; 93.394, Cancer Detection and Drive, Room 5210, MSC 7846, Bethesda, MD
Richard U. Rodriguez, Diagnosis Research; 93.395, Cancer 20892, (301) 435–1246,
Treatment Research; 93.396, Cancer Biology edwardss@csr.nih.gov.
Acting Director, Office of Technology
Research; 93.397, Cancer Centers Support; This notice is being published less than 15
Transfer, National Institutes of Health.
93.398, Cancer Research Manpower; 93.399, days prior to the meeting due to the timing
[FR Doc. 2015–06486 Filed 3–20–15; 8:45 am] Cancer Control, National Institutes of Health, limitations imposed by the review and
BILLING CODE 4140–01–P HHS) funding cycle.

VerDate Sep<11>2014 16:51 Mar 20, 2015 Jkt 235001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1

15228 Federal Register / Vol. 80, No. 55 / Monday, March 23, 2015 / Notices

(Catalogue of Federal Domestic Assistance proposed collection of information, together cancer biologists and
Program Nos. 93.306, Comparative Medicine; including the validity of the oncologists with scientists from the
93.333, Clinical Research, 93.306, 93.333, methodology and assumptions used; (3) fields of physics, mathematics,
93.337, 93.393–93.396, 93.837–93.844, Ways to enhance the quality, utility, and
93.846–93.878, 93.892, 93.893, National
chemistry, and engineering to address
Institutes of Health, HHS) clarity of the information to be some of the major questions and barriers
collected; and (4) Ways to minimize the in cancer research. As part of this
burden of the collection of information initiative, evaluation plans were
Dated: March 18, 2015.
on those who are to respond, including developed and consisted of three
Michelle Trout,
the use of appropriate automated, components, dependent on which year
Program Analyst, Office of Federal Advisory electronic, mechanical, or other the initiative is in: Prospective for
Committee Policy.
technological collection techniques or beginning, structured for mid-point, and
[FR Doc. 2015–06596 Filed 3–20–15; 8:45 am] other forms of information technology. summative/full outcome evaluation for
BILLING CODE 4140–01–P To Submit Comments And For a decade after the program started. In
Further Information: To obtain a copy of 2015 the PSO Initiative is transitioning
the data collection plans and from the beginning to a mid-point
DEPARTMENT OF HEALTH AND instruments, submit comments in
HUMAN SERVICES phase, which represents a critical time
writing, or request more information on to reflect on the initial outcomes and
the proposed project, contact: Nicole restructure the process evaluation to
National Institutes of Health
Moore, Division of Cancer Biology, 9609 account for changes mid-way through
Proposed Collection; 60-Day Comment Medical Center Drive, Room 6W508, the initiative. This proposed request is
Request; Process and Outcomes Bethesda, MD 20892–9714 or call non- to conduct on-line surveys with current
Evaluation of NCI Physical Sciences in toll-free number 301–325–7534 or Email and former trainees and NCI grantees
Oncology Centers (PS–OC) Initiative your request, including your address to: associated with the program and
(NCI) Nicole.Moore@nih.gov. Formal requests comparison groups. Additionally, an
for additional plans and instruments assessment of publications generated
SUMMARY: In compliance with the must be requested in writing. through the PS–OC program will be
requirement of Section 3506(c)(2)(A) of Comment Due Date: Comments
the Paperwork Reduction Act of 1995, conducted via a virtual expert review
regarding this information collection are
for opportunity for public comment on panel. The evaluation will address
best assured of having their full effect if
proposed data collection projects, the trainee development and career path
received within 60 days of the date of
National Cancer Institute (NCI), post program involvement as well as the
this publication.
National Institutes of Health (NIH), will impact of the program involvement on
publish periodic summaries of proposed Proposed Collection: Process and program outputs. Results from both the
projects to be submitted to the Office of Outcomes Evaluation of NCI Physical surveys and the expert peer reviewer
Management and Budget (OMB) for Sciences in Oncology Centers (PS–OC) panel will assess research innovation
review and approval. Initiative (NCI), 0925–NEW, National from the program and inform the future
Written comments and/or suggestions Cancer Institute (NCI), National development of the PSO Initiative. This
from the public and affected agencies Institutes of Health (NIH) request is to gain OMB approval for the
are invited on one or more of the Need and Use of Information new submission titled, ‘‘Process and
following points: (1) Whether the Collection: The NCI launched the Outcomes Evaluation of NCI Physical
proposed collection of information is Physical Sciences—Oncology Center Sciences in Oncology Centers (PS–OC)
necessary for the proper performance of (PS–OC; http://physics.cancer.gov/) Initiative (NCI)’’ for 1 year.
the function of the agency, including program in 2009 as Phase I of the OMB approval is requested for 1 year.
whether the information will have Physical Sciences in Oncology (PSO) There are no costs to respondents other
practical utility; (2) The accuracy of the Initiative. The PSO Initiative seeks to than their time. The total estimated
agency’s estimate of the burden of the establish research projects that bring annualized burden hours are 955.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total annual
Instrument Type of respondent responses per
respondents response burden hour
respondent (in hours)

Survey ............................................... Current NCI Trainees ....................... 210 1 25/60 88
Survey ............................................... Former NCI Trainees ....................... 340 1 25/60 142
Survey ............................................... NCI Grantees ................................... 300 1 25/60 125
Scoring Sheet ................................... Expert Reviewers ............................. 75 1 8 600

Dated: March 16, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National
mstockstill on DSK4VPTVN1PROD with NOTICES

Institutes of Health.
[FR Doc. 2015–06535 Filed 3–20–15; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014 16:51 Mar 20, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 9990 E:\FR\FM\23MRN1.SGM 23MRN1

Document Created: 2018-02-21 09:47:31
Document Modified: 2018-02-21 09:47:31

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		April 2, 2015.
FR Citation		80 FR 15227

80 FR 15227 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 55 (March 23, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health